Distal anoctaminopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:399096OMIM:613319G71.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal anoctaminopathy is a rare inherited muscle disease that primarily affects the muscles farthest from the center of the body, especially those in the lower legs and feet. It is caused by mutations in the ANO5 gene (also known as TMEM16E), which provides instructions for making a protein involved in muscle cell membrane repair. When this protein does not work properly, muscle fibers gradually break down over time. The disease typically begins in adulthood, often between the ages of 20 and 50. Early symptoms usually include difficulty walking, tripping, or weakness in the calves and feet. Over time, the weakness may spread to involve other muscles in the legs and sometimes the arms. Some people also experience elevated levels of creatine kinase (CK) in their blood, which is a marker of muscle damage. The rate of progression varies from person to person — some individuals remain relatively mildly affected for many years, while others may eventually need assistive devices for walking. There is currently no cure for distal anoctaminopathy. Treatment focuses on managing symptoms and maintaining function through physical therapy, assistive devices, and regular monitoring by a neuromuscular specialist. Research into potential therapies, including gene therapy approaches, is ongoing but still in early stages. The condition is also sometimes referred to as distal ANO5-related myopathy or Miyoshi-type distal myopathy caused by ANO5 mutations.

Also known as:

Key symptoms:

Weakness in the calf musclesDifficulty walking or frequent trippingFoot drop (trouble lifting the front of the foot)Muscle wasting in the lower legsDifficulty standing on tiptoesElevated creatine kinase levels in blood testsMuscle pain or crampingDifficulty climbing stairsAsymmetric muscle weakness (one side worse than the other)Gradual loss of ability to walk long distancesWeakness in the thigh muscles over timeSwelling of calf muscles early in the disease

Clinical phenotype terms (13)— hover any for plain English
Progressive muscle weaknessHP:0003323Highly elevated creatine kinaseHP:0030234Calf muscle pseudohypertrophyHP:0003707Proximal upper limb muscle weaknessHP:0008997Progressive proximal muscle weaknessHP:0009073RhabdomyolysisHP:0003201Peroneal muscle atrophyHP:0009049
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal anoctaminopathy.

View clinical trials →

No actively recruiting trials found for Distal anoctaminopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal anoctaminopathy community →

No specialists are currently listed for Distal anoctaminopathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal anoctaminopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal anoctaminopathyForum →

No community posts yet. Be the first to share your experience with Distal anoctaminopathy.

Start the conversation →

Latest news about Distal anoctaminopathy

No recent news articles for Distal anoctaminopathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the expected rate of progression for my specific case?,What types of exercise are safe and beneficial for me?,Should my family members be tested for ANO5 mutations?,Are there any clinical trials or research studies I could participate in?,When should I consider using assistive devices like ankle braces or a cane?,How often should I have follow-up appointments and what tests will be done?,Are there any activities or medications I should avoid to protect my muscles?

Common questions about Distal anoctaminopathy

What is Distal anoctaminopathy?

Distal anoctaminopathy is a rare inherited muscle disease that primarily affects the muscles farthest from the center of the body, especially those in the lower legs and feet. It is caused by mutations in the ANO5 gene (also known as TMEM16E), which provides instructions for making a protein involved in muscle cell membrane repair. When this protein does not work properly, muscle fibers gradually break down over time. The disease typically begins in adulthood, often between the ages of 20 and 50. Early symptoms usually include difficulty walking, tripping, or weakness in the calves and feet.

How is Distal anoctaminopathy inherited?

Distal anoctaminopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Distal anoctaminopathy typically begin?

Typical onset of Distal anoctaminopathy is adult. Age of onset can vary across affected individuals.